ArticleBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine2026
New insights on the role of some biometals in mancozeb induced hematological and hepatorenal toxicity in rats and the protective effect of naringin.
Article in Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prolonged exposure to mancozeb (MZ), a frequently used fungicide, may cause oxidative stress damage to several organs; however, the mechanism of toxicity remains obscure. So, the present work sought to assess the contribution of some biometals, including Mn, Zn, Ca, and Fe, to the subacute hepatic and renal injury prompted by MZ-mediated oxidative stress and to evaluate the protective impact of naringin (NAR), a citrus-derived flavonoid, against this toxicity. Twenty-eight male Wistar rats were divided into four groups (n = 7) as follows: (1) control, (2) NAR (20 mg/kg bwt), (3) MZ (250 mg/kg bwt), and (4) NAR + MZ. The daily oral intake of MZ for 54 days induced marked hematological alterations, elevation in some hepatorenal markers, and alteration of the redox status of both liver and kidney tissues. There were marked histopathological alterations in both liver and kidney tissues that were confirmed by the immunohistochemical staining, which demonstrated strong iNOS and Bax along with weak Bcl-2 immunoexpression. The repeated exposure to MZ significantly increased the levels of Mn and decreased the levels of Ca, Zn, and Fe in both liver and kidney tissues, which attributed to upregulation of the mRNA levels of MT-1, CYP1A1, and casp-3 genes. On the other hand, the co-administration of NAR with MZ significantly reversed these toxic effects via improving the hematological profile, restoring antioxidant enzyme activity, and mitigating both hepatorenal function and structure. The data indicated that NAR had considerable protective effects against MZ-induced hepatorenal damage, mostly through enhanced antioxidant capacity, preservation of trace element equilibrium, and modulation of oxidative, inflammatory, and apoptotic pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.